Clinical Trial Update: A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of GSK4532990 versus placebo in adults with alcoholic liver disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Disease

Drugs mentioned

• GSK4532990

Snippet

Sponsor: GlaxoSmithKline | Conditions: Liver Diseases, Alcoholic | Phase 2 | Status: RECRUITING